Potential use an Actinobacillus pleuropneumoniae double mutant strain ΔapxIICΔapxIVA as live vaccine that allows serological differentiation between vaccinated and infected animals

Vaccine

Volumn 25, Issue 44, 2007, Pages 7696-7705

  Liu, Jinlin ^a   Chen, Xia ^a   Lin, Liwen ^a   Tan, Chen ^a   Chen, Yan ^a   Guo, Yi ^a   Jin, Meilin ^a   Guo, Aizhen ^a   Bei, Weicheng ^a   Chen, Huanchun ^a  

^a HUAZHONG AGRICULTURAL UNIVERSITY   (China)

Author keywords

Actinobacillus pleuropneumoniae; Double mutant; Live vaccine; Serological differential diagnosis

Indexed keywords

ACTINOBACILLUS PLEUROPNEUMONIAE VACCINE; LIVE VACCINE; UNCLASSIFIED DRUG; VIRULENCE FACTOR;

ACTINOBACILLUS PLEUROPNEUMONIAE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; CONTROLLED STUDY; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPERIMENTAL INFECTION; FEMALE; HUMORAL IMMUNITY; IMMUNITY; IMMUNIZATION; IMMUNOGENICITY; INFECTION PREVENTION; LD 50; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEROTYPE; SOLID; STATISTICAL ANALYSIS; SWINE; TREATMENT DURATION; VACCINATION;

ACTINOBACILLUS PLEUROPNEUMONIAE; ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL PROTEINS; BACTERIAL VACCINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMOLYSIN PROTEINS; IMMUNOGLOBULIN G; MICE; MICE, INBRED BALB C; MUTATION; SWINE; VACCINATION; VACCINES, ATTENUATED; VACCINES, SYNTHETIC;

EID: 35148866801     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2007.07.053     Document Type: Article

References (38)

1. Fenwick B., and Henry S. Porcine pleuropneumonia. J Am Vet Med Assoc 204 9 (1994) 1334-1340
2. Blackall P.J., Klaasen H.L., van den Bosch H., Kuhnert P., and Frey J. Proposal of a new serovar of Actinobacillus pleuropneumoniae: serovar 15. Vet Microbiol 84 1-2 (2002) 47-52
3. Bandara A.B., Lawrence M.L., Veit H.P., and Inzana T.J. Association of Actinobacillus pleuropneumoniae capsular polysaccharide with virulence in pigs. Infect Immun 71 6 (2003) 3320-3328
4. Udeze F.A., Latimer K.S., and Kadis S. Role of Haemophilus pleuropneumoniae lipopolysaccharide endotoxin in the pathogenesis of porcine Haemophilus pleuropneumonia. Am J Vet Res 48 5 (1987) 768-773
5. Baltes N., Hennig-Pauka I., and Gerlach G.F. Both transferrin binding proteins are virulence factors in Actinobacillus pleuropneumoniae serotype 7 infection. FEMS Microbiol Lett 209 2 (2002) 283-287
6. Dom P., Haesebrouck F., Ducatelle R., and Charlier G. In vivo association of Actinobacillus pleuropneumoniae serotype 2 with the respiratory epithelium of pigs. Infect Immun 62 4 (1994) 1262-1267
7. Negrete-Abascal E., Reyes M.E., Garcia R.M., Vaca S., Giron J.A., Garcia O., et al. Flagella and motility in Actinobacillus pleuropneumoniae. J Bacteriol 185 2 (2003) 664-668
8. Jacobsen I., Hennig-Pauka I., Baltes N., Trost M., and Gerlach G.F. Enzymes involved in anaerobic respiration appear to play a role in Actinobacillus pleuropneumoniae virulence. Infect Immun 73 1 (2005) 226-234
9. Tascon R.I., Vazquez Boland J.A., Gutierrez Martin C.B., Rodriguez Barbosa I., and Rodriguez Ferri E.F. The RTX haemolysins ApxI and ApxII are major virulence factors of the swine pathogen Actinobacillus pleuropneumoniae: evidence from mutational analysis. Mol Microbiol 14 2 (1994) 207-216
10. Frey J. Virulence in Actinobacillus pleuropneumoniae and RTX toxins. Trends Microbiol 3 7 (1995) 257-261
11. Haesebrouck F., Chiers K., Van Overbeke I., and Ducatelle R. Actinobacillus pleuropneumoniae infections in pigs: the role of virulence factors in pathogenesis and protection. Vet Microbiol 58 2-4 (1997) 239-249
12. Schaller A., Kuhn R., Kuhnert P., Nicolet J., Anderson T.J., MacInnes J.I., et al. Characterization of apxIVA, a new RTX determinant of Actinobacillus pleuropneumoniae. Microbiology 145 8 (1999) 2105-2116
13. Maier E., Reinhard N., Benz R., and Frey J. Channel-forming activity and channel size of the RTX toxins ApxI, ApxII, and ApxIII of Actinobacillus pleuropneumoniae. Infect Immun 64 11 (1996) 4415-4423
14. Nielsena R., van den Bosch J.F., Plambeck T., Sorensen V., and Nielsen J.P. Evaluation of an indirect enzyme-linked immunosorbent assay (ELISA) for detection of antibodies to the Apx toxins of Actinobacillus pleuropneumoniae. Vet Microbiol 71 1-2 (2000) 81-87
15. Frey J., and Kuhnert P. RTX toxins in Pasteurellaceae. Int J Med Microbiol 292 3-4 (2002) 149-158
16. Higgins R., Lariviere S., Mittal K.R., Martineau G.P., Rousseau P., and Cameron J. Evaluation of a killed vaccine against porcine pleuropneumonia due to Haemophilus pleuropneumoniae. Can Vet J 26 2 (1985) 86-89
17. Jolie R.A., Mulks M.H., and Thacker B.J. Cross-protection experiments in pigs vaccinated with Actinobacillus pleuropneumoniae subtypes 1A and 1B. Vet Microbiol 45 4 (1995) 383-391
18. Cruijsen T., van Leengoed L.A., Ham-Hoffies M., and Verheijden J.H. Convalescent pigs are protected completely against infection with a homologous Actinobacillus pleuropneumoniae strain but incompletely against a heterologous-serotype strain. Infect Immun 63 3 (1995) 2341-2343
19. Mulks M.H., and Buysse J.M. A targeted mutagenesis system for Actinobacillus pleuropneumoniae. Gene 165 1 (1995) 61-66
20. Fuller T.E., Thacker B.J., and Mulks M.H. A riboflavin auxotroph of Actinobacillus pleuropneumoniae is attenuated in swine. Infect Immun 64 11 (1996) 4659-4664
21. Rioux S., Begin C., Dubreuil J.D., and Jacques M. Isolation and characterization of LPS mutants of Actinobacillus pleuropneumoniae serotype 1. Curr Microbiol 35 3 (1997) 139-144
22. Oswald W., Tonpitak W., Ohrt G., and Gerlach G.F. A single-step transconjugation system for the introduction of unmarked deletions into Actinobacillus pleuropneumoniae serotype 7 using a sucrose sensitivity marker. FEMS Microbiol Lett 179 1 (1999) 153-160
23. Bosse J.T., Nash J.H., Kroll J.S., and Langford P.R. Harnessing natural transformation in Actinobacillus pleuropneumoniae: a simple method for allelic replacements. FEMS Microbiol Lett 233 2 (2004) 277-281
24. Maas A., Jacobsen I.D., Meens J., and Gerlach G.F. Use of an Actinobacillus pleuropneumoniae multiple mutant as a vaccine that allows differentiation of vaccinated and infected animals. Infect Immun 74 7 (2006) 4124-4132
25. Turni C., and Blackall P.J. An evaluation of the apxIVA based PCR-REA method for differentiation of Actinobacillus pleuropneumoniae. Vet Microbiol 31 1-2 (2007) 163-169
26. Bei W., He Q., Yan L., Fang L., Tan Y., Xiao S., et al. Construction and characterisation of a live, attenuated apxIICA inactivation mutant of Actinobacillus pleuropneumoniae lacking a drug resistance marker. FEMS Microbiol Lett 243 1 (2005) 21-27
27. Liang W., and He Q. Cloning and expression of ApxIIA and development of an indirect ELISA for detection of antibodies against A. pleuropneumoniae. Chin J Vet 25 2 (2005) 145-147 [article in Chinese]
28. Huang H., Zhou R., Chen M., Liu J., Xu X., and Chen H. Cloning and expression of the apxIVA gene of Actionbacillus pleuroneumoniae and development of an indirect ApxIVA-ELISA. Chin J Biotechnol 21 2 (2004) 294-299 [article in Chinese]
29. Fuller T.E., Thacker B.J., Duran C.O., and Mulks M.H. A genetically-defined riboflavin auxotroph of Actinobacillus pleuropneumoniae as a live attenuated vaccine. Vaccine 18 25 (2000) 2867-2877
30. Hannan P.C., Bhogal B.S., and Fish J.P. Tylosin tartrate and tiamutilin effects on experimental piglet pneumonia induced with pneumonic pig lung homogenate containing mycoplasmas, bacteria and viruses. Res Vet Sci 33 1 (1982) 76-88
31. Madsen M.E., Carnahan K.G., and Thwaits R.N. Evaluation of pig lungs following an experimental challenge with Actinobacillus pleuropneumoniae serotype 1 and 5 in pigs inoculated with either hemolysin protein and/or outer membrane proteins. FEMS Microbiol Lett 131 3 (1995) 329-335
32. Van Overbeke I., Chiers K., Ducatelle R., and Haesebrouck F. Effect of endobronchial challenge with Actinobacillus pleuropneumoniae serotype 9 of pigs vaccinated with a vaccine containing Apx toxins and transferrin-binding proteins. J Vet Med 48 1 (2001) 15-20
33. Haesebrouk F., Van de kerkhof A., Dom P., Chiers K., and Ducatelle R. Cross-protection between Actinobacillus pleuropneumoniae biotypes-serotypes in pigs. Vet Microbiol 52 3-4 (1996) 277-284
34. Prideaux C.T., Lenghaus C., Krywult J., and Hodgson A.L. Vaccination and protection of pigs against pleuropneumonia with a vaccine strain of Actinobacillus pleuropneumoniae produced by site-specific mutagenesis of the ApxII operon. Infect Immun 67 (1999) 1962-1966
35. Lee K.Y., Kim D.H., Kang T.J., Kim J., Chung G.H., Yoo H.S., et al. Induction of protective immune responses against the challenge of Actinobacillus pleuropneumoniae by the oral administration of transgenic tobacco plant expressing ApxIIA toxin from the bacteria. FEMS Immunol Med Microbiol 48 3 (2006) 381-389
36. Schaller A., Kuhner P., de la Puente-Redondo V.A., Nicolet J., and Frey J. Apx toxins in Pasteurellaceae species from animals. Vet Microbiol 74 4 (2000) 365-376
37. Gottschalk M., Broes A., Mittal K.R., Kobisch M., Kuhnert P., Lebrun A., et al. Non-pathogenic Actinobacillus isolates antigenically and biochemically similar to Actinobacillus pleuropneumoniae: a novel species?. Vet Microbiol 92 1-2 (2003) 87-101
38. Guan K.L., and Dixon J.E. Eukaryotic proteins expressed in Escherichia coli: an improved thrombin cleavage and purification procedure of fusion proteins with glutathione S-transferase. Anal Biochem 192 2 (1991) 262-267